Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Albuterol | 1 | 2020 | 208 | 0.670 |
Why?
|
| Pharmacogenetics | 3 | 2021 | 675 | 0.640 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 231 | 0.610 |
Why?
|
| Pharmacists | 1 | 2018 | 248 | 0.540 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 204 | 0.500 |
Why?
|
| Medication Errors | 2 | 2018 | 798 | 0.490 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 436 | 0.470 |
Why?
|
| Hospitals, Pediatric | 6 | 2022 | 1775 | 0.470 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1086 | 0.430 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 1637 | 0.420 |
Why?
|
| Neuropeptides | 1 | 2018 | 942 | 0.420 |
Why?
|
| Methyltransferases | 1 | 2014 | 367 | 0.390 |
Why?
|
| Gene Deletion | 1 | 2018 | 2751 | 0.360 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1916 | 0.310 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4468 | 0.270 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2018 | 133 | 0.240 |
Why?
|
| Asthma | 2 | 2020 | 6011 | 0.210 |
Why?
|
| Fluvoxamine | 1 | 2022 | 74 | 0.210 |
Why?
|
| Genetic Testing | 2 | 2019 | 3444 | 0.210 |
Why?
|
| Amphetamines | 1 | 2002 | 148 | 0.200 |
Why?
|
| Analgesics | 2 | 2020 | 1040 | 0.200 |
Why?
|
| Patient Discharge | 3 | 2023 | 3313 | 0.200 |
Why?
|
| Disaster Planning | 3 | 2022 | 549 | 0.200 |
Why?
|
| Pharmacy | 1 | 2022 | 91 | 0.180 |
Why?
|
| Benzalkonium Compounds | 1 | 2020 | 24 | 0.180 |
Why?
|
| Substance Abuse Detection | 1 | 2002 | 283 | 0.180 |
Why?
|
| Child | 20 | 2023 | 77709 | 0.170 |
Why?
|
| Mass Casualty Incidents | 1 | 2022 | 183 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 92 | 0.170 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2019 | 77 | 0.160 |
Why?
|
| Off-Label Use | 1 | 2020 | 169 | 0.160 |
Why?
|
| Methylphenidate | 1 | 2002 | 473 | 0.160 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 7659 | 0.160 |
Why?
|
| Analgesia | 2 | 2018 | 461 | 0.150 |
Why?
|
| Dexmedetomidine | 1 | 2022 | 315 | 0.150 |
Why?
|
| Epilepsy, Generalized | 1 | 2019 | 174 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 632 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2020 | 502 | 0.140 |
Why?
|
| Cross Reactions | 1 | 2018 | 841 | 0.140 |
Why?
|
| Needlestick Injuries | 1 | 2015 | 67 | 0.130 |
Why?
|
| Child, Preschool | 12 | 2020 | 41006 | 0.130 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 1917 | 0.130 |
Why?
|
| Alleles | 2 | 2018 | 6933 | 0.130 |
Why?
|
| Medical History Taking | 2 | 2010 | 783 | 0.120 |
Why?
|
| Finger Injuries | 1 | 2015 | 139 | 0.120 |
Why?
|
| Lacerations | 1 | 2015 | 144 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 1148 | 0.120 |
Why?
|
| Leg Injuries | 1 | 2015 | 178 | 0.120 |
Why?
|
| Molecular Structure | 1 | 2018 | 1899 | 0.110 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 151 | 0.110 |
Why?
|
| Vomiting | 2 | 2015 | 636 | 0.110 |
Why?
|
| Disasters | 2 | 2011 | 511 | 0.110 |
Why?
|
| Cannabinoids | 1 | 2015 | 166 | 0.110 |
Why?
|
| Epinephrine | 1 | 2015 | 792 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2015 | 1460 | 0.100 |
Why?
|
| Benzocaine | 1 | 2011 | 15 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1041 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 2015 | 399 | 0.100 |
Why?
|
| Marijuana Abuse | 1 | 2015 | 403 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2018 | 1092 | 0.090 |
Why?
|
| Outpatients | 1 | 2018 | 1486 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2013 | 3589 | 0.090 |
Why?
|
| Infant | 5 | 2019 | 35136 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1537 | 0.080 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1127 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2016 | 1164 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2015 | 746 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2015 | 981 | 0.070 |
Why?
|
| Pediatrics | 5 | 2012 | 3475 | 0.070 |
Why?
|
| Warfarin | 1 | 2015 | 1496 | 0.070 |
Why?
|
| Humans | 28 | 2023 | 744343 | 0.070 |
Why?
|
| Rescue Work | 1 | 2006 | 56 | 0.070 |
Why?
|
| Information Management | 1 | 2006 | 101 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1584 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 1049 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2011 | 1205 | 0.060 |
Why?
|
| Disclosure | 1 | 2010 | 736 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6544 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4251 | 0.060 |
Why?
|
| Adolescent | 8 | 2021 | 85781 | 0.060 |
Why?
|
| Triage | 2 | 2006 | 976 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77449 | 0.050 |
Why?
|
| Weaning | 1 | 2022 | 105 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2012 | 1439 | 0.050 |
Why?
|
| Patient Participation | 1 | 2010 | 1457 | 0.050 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.050 |
Why?
|
| Safety Management | 1 | 2006 | 783 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2012 | 2063 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2212 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2015 | 4599 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2003 | 528 | 0.040 |
Why?
|
| Female | 10 | 2020 | 380194 | 0.040 |
Why?
|
| Drug Labeling | 1 | 2021 | 233 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2019 | 168 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4558 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 4584 | 0.040 |
Why?
|
| Transportation of Patients | 2 | 2011 | 185 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 884 | 0.040 |
Why?
|
| Relief Work | 2 | 2011 | 137 | 0.040 |
Why?
|
| Fasting | 1 | 2003 | 1593 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 2 | 2022 | 1162 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 23338 | 0.040 |
Why?
|
| Parents | 2 | 2010 | 3407 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2016 | 256 | 0.030 |
Why?
|
| United States | 5 | 2020 | 69872 | 0.030 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2015 | 35 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2015 | 110 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 1071 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 264 | 0.030 |
Why?
|
| Self Administration | 1 | 2015 | 385 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 552 | 0.030 |
Why?
|
| Male | 8 | 2020 | 350118 | 0.030 |
Why?
|
| Boston | 2 | 2019 | 9313 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2015 | 367 | 0.030 |
Why?
|
| Disabled Children | 1 | 2015 | 247 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 547 | 0.030 |
Why?
|
| Southwestern United States | 1 | 2011 | 37 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2015 | 469 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2011 | 95 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2539 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1063 | 0.020 |
Why?
|
| Security Measures | 1 | 2011 | 77 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2274 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 526 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2012 | 317 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8324 | 0.020 |
Why?
|
| Critical Illness | 1 | 2022 | 2670 | 0.020 |
Why?
|
| Graft Survival | 1 | 2019 | 3737 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1257 | 0.020 |
Why?
|
| Patient Admission | 1 | 2015 | 1380 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2494 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7149 | 0.020 |
Why?
|
| Emergency Medical Tags | 1 | 2006 | 3 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 3658 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 13815 | 0.020 |
Why?
|
| United States Government Agencies | 1 | 2006 | 26 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 1186 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
| Louisiana | 1 | 2006 | 108 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4397 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 1147 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6489 | 0.020 |
Why?
|
| Chloral Hydrate | 1 | 2003 | 29 | 0.010 |
Why?
|
| Laryngismus | 1 | 2003 | 29 | 0.010 |
Why?
|
| Anesthetics, Combined | 1 | 2003 | 40 | 0.010 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2003 | 57 | 0.010 |
Why?
|
| Pentobarbital | 1 | 2003 | 155 | 0.010 |
Why?
|
| Counseling | 1 | 2011 | 1523 | 0.010 |
Why?
|
| Lorazepam | 1 | 2003 | 145 | 0.010 |
Why?
|
| Diazepam | 1 | 2003 | 205 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 2003 | 177 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 1177 | 0.010 |
Why?
|
| Midazolam | 1 | 2003 | 270 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2278 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
| Fentanyl | 1 | 2003 | 410 | 0.010 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 545 | 0.010 |
Why?
|
| Documentation | 1 | 2006 | 871 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2003 | 517 | 0.010 |
Why?
|
| Internet | 1 | 2011 | 3064 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
| Medicaid | 1 | 2012 | 2736 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
| Health Personnel | 1 | 2011 | 3218 | 0.010 |
Why?
|
| Ketamine | 1 | 2003 | 500 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 884 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5137 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 213383 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 214055 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2003 | 2266 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 4215 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14722 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7279 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2003 | 53288 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 72290 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_